Jingyi Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jingyi Guo has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Litong Yao
Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, China
2 shared publications - Mengshen Wang
Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China
2 shared publications - Mozhi Wang
Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, China
2 shared publications - Xinyan Li
State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2 shared publications - Xueting Yu
Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China
2 shared publications - Yingying Xu
Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.
2 shared publications
Latest Publications
- Open Access
- 23 February 2023
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 18 (4) , 1-9
Retrospective analysis of Porphyromonas gingivalis in patients with nasopharyngeal carcinoma in central China
Little is known about the presence and possible role of Porphyromonas gingivalis (P. gingivalis) in nasopharyngeal carcinoma (NPC), its co‑infection with Epstein‑Barr virus (EBV), or their association with clinical characteristics of patients with NPC in Central China, where NPC is non‑endemic. A total of 45 NPC formalin‑fixed paraffin‑embedded (FFPE) tissues were retrospectively analyzed using immunohistochemistry (IHC) and a nested PCR combined with DNA sequencing to detect the presence of P. gingivalis, and using reverse transcription‑quantitative PCR to detect the presence of EBV. Clinical data including EBV and P. gingivalis status were associated with overall survival (OS). All tumors were undifferentiated, non‑keratinizing carcinomas, of which 40/45 (88.9%) were positive for EBV (EBV+), 26/45 (57.8%) were positive for P. gingivalis (by IHC), and 7/45 (15.6%) were positive for P. gingivalis DNA (P. gingivalis+). All seven P. gingivalis DNA‑positive NPCs were co‑infected with EBV. The 5‑year survival rates of the patients with EBV‑/P. gingivalis‑, EBV+/P. gingivalis‑, and EBV+/P. gingivalis+ tumors were 60.0% (3/5), 39.4% (13/33) and 42.9% (3/7), respectively. No significant difference was found between the OS of NPC patients among the different infection groups (P=0.793). In conclusion, to the best of our knowledge, this is the first study to describe and confirm the presence of P. gingivalis in FFPE tissues from patients with NPC. P. gingivalis was found to co‑exist with EBV in NPC tumor tissues, but is not etiologically relevant to NPC in non‑endemic areas, such as Central China.
- 23 February 2023
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 18 (4) , 1-9
Open AccessRetrospective analysis of Porphyromonas gingivalis in patients with nasopharyngeal carcinoma in central China
Little is known about the presence and possible role of Porphyromonas gingivalis (P. gingivalis) in nasopharyngeal carcinoma (NPC), its co‑infection with Epstein‑Barr virus (EBV), or their association with clinical characteristics of patients with NPC in Central China, where NPC is non‑endemic. A total of 45 NPC formalin‑fixed paraffin‑embedded (FFPE) tissues were retrospectively analyzed using immunohistochemistry (IHC) and a nested PCR combined with DNA sequencing to detect the presence of P. gingivalis, and using reverse transcription‑quantitative PCR to detect the presence of EBV. Clinical data including EBV and P. gingivalis status were associated with overall survival (OS). All tumors were undifferentiated, non‑keratinizing carcinomas, of which 40/45 (88.9%) were positive for EBV (EBV+), 26/45 (57.8%) were positive for P. gingivalis (by IHC), and 7/45 (15.6%) were positive for P. gingivalis DNA (P. gingivalis+). All seven P. gingivalis DNA‑positive NPCs were co‑infected with EBV. The 5‑year survival rates of the patients with EBV‑/P. gingivalis‑, EBV+/P. gingivalis‑, and EBV+/P. gingivalis+ tumors were 60.0% (3/5), 39.4% (13/33) and 42.9% (3/7), respectively. No significant difference was found between the OS of NPC patients among the different infection groups (P=0.793). In conclusion, to the best of our knowledge, this is the first study to describe and confirm the presence of P. gingivalis in FFPE tissues from patients with NPC. P. gingivalis was found to co‑exist with EBV in NPC tumor tissues, but is not etiologically relevant to NPC in non‑endemic areas, such as Central China.
- 16 August 2021
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 29 (3) , 4093-4100
Can static electric fields increase the activity of nitric oxide synthase and induce oxidative stress and damage of spleen?
With the rapid development of ultra-high-voltage (UHV) direct-current (DC) transmissions, the impact of static electric fields (SEF) in the vicinity of overhead UHV DC transmission lines on health has aroused much public concern. This study explored the effects of 56.3kV/m SEF on the spleen of mice. Results showed that SEF exposure of 21days significantly increased malonic dialdehyde content, superoxide dismutase activity, calcineurin activity, nitric oxide synthase (NOS) activity, and the mRNA expression levels of tumor necrosis factor-α (TNF-α) and nuclear factor-κB (NF-κB) in the spleen and caused the separation of nucleus and nuclear membrane, the disappearance of mitochondrial membrane, and the deficiency of mitochondrial cristae in splenic lymphocytes. By analysis and discussion, it was deduced that SEF could induce oxidative stress of the spleen by increasing the activity of NOS. Oxidative stress could further cause ultrastructural changes of splenic lymphocytes. Moreover, oxidative stress could cause the increase of the mRNA expression levels of TNF-α and NF-κB, which contributed to the occurrence of spleen inflammation.
- 16 August 2021
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 29 (3) , 4093-4100
Can static electric fields increase the activity of nitric oxide synthase and induce oxidative stress and damage of spleen?
With the rapid development of ultra-high-voltage (UHV) direct-current (DC) transmissions, the impact of static electric fields (SEF) in the vicinity of overhead UHV DC transmission lines on health has aroused much public concern. This study explored the effects of 56.3kV/m SEF on the spleen of mice. Results showed that SEF exposure of 21days significantly increased malonic dialdehyde content, superoxide dismutase activity, calcineurin activity, nitric oxide synthase (NOS) activity, and the mRNA expression levels of tumor necrosis factor-α (TNF-α) and nuclear factor-κB (NF-κB) in the spleen and caused the separation of nucleus and nuclear membrane, the disappearance of mitochondrial membrane, and the deficiency of mitochondrial cristae in splenic lymphocytes. By analysis and discussion, it was deduced that SEF could induce oxidative stress of the spleen by increasing the activity of NOS. Oxidative stress could further cause ultrastructural changes of splenic lymphocytes. Moreover, oxidative stress could cause the increase of the mRNA expression levels of TNF-α and NF-κB, which contributed to the occurrence of spleen inflammation.
- Open Access
- 1 January 2020
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 23 (4) , 410-429
Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer
Li X, et al. J Breast Cancer. 2019 Nov;23:e45. https://doi.org/10.4048/jbc.2020.23.e45
- 1 January 2020
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 23 (4) , 410-429
Open AccessUpdated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer
Li X, et al. J Breast Cancer. 2019 Nov;23:e45. https://doi.org/10.4048/jbc.2020.23.e45
- Open Access
- 1 January 2019
- Published by XMLink in Journal of Breast Cancer
- Vol. 22 (4) , 497-521
Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
Li X, et al. J Breast Cancer. 2019 Jul;22:e49. https://doi.org/10.4048/jbc.2019.22.e49
- 1 January 2019
- Published by XMLink in Journal of Breast Cancer
- Vol. 22 (4) , 497-521
Open AccessPredictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
Li X, et al. J Breast Cancer. 2019 Jul;22:e49. https://doi.org/10.4048/jbc.2019.22.e49